Chronic Hepatitis B and Hepatitis D Virus Infection

被引:0
作者
Rusignuolo, Giuseppe [1 ,2 ]
Thimme, Robert [1 ]
Neumann-Haefelin, Christoph [1 ,2 ]
机构
[1] Uni Klin Freiburg, Klin Innere Med 2, Freiburg, Germany
[2] Gerok Leberzentrum, Freiburg, Germany
关键词
Hepatitis-B-Virus; Hepatitis-D-Virus; Therapie; antiviral; Entecavir; Tenofovir; Bulevirtid; hepatitis B virus; hepatitis D virus; therapy; entecavir; tenofovir; bulevirtide; BULEVIRTIDE; EFFICACY; PHASE-3; SAFETY; TRIAL;
D O I
10.1055/a-2057-1840
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Eine unbehandelte chronische Hepatitis-B-Virus-Infektion kann bis zur Leberzirrhose und zum hepatozellul & auml;ren Karzinom fortschreiten, was durch eine rechtzeitige Diagnose und eine antivirale Therapie verhindert werden kann. Eine Heilung ist bisher aber in der Regel nicht m & ouml;glich. Eine Koinfektion mit dem Hepatitis-D-Virus erh & ouml;ht das Risiko einer Leberzirrhose. Auch f & uuml;r die Hepatitis D steht inzwischen eine effektive Therapie zur Verf & uuml;gung. About 0,5% of the population in Germany has a chronic hepatitis B virus (HBV) infection. Untreated, chronic HBV infection can progress to liver cirrhosis and hepatocellular carcinoma (HCC). If diagnosed early, antiviral therapy can effectively prevent liver disease progression, but a cure is currently hardly achievable. About 5% of those chronically infected with HBV are also co-infected with the hepatitis D virus (HDV). HBV/HDV co-infection leads to liver cirrhosis in approximately 50% of patients within 5-10 years. Since 2020, the cell entry inhibitor bulevirtide is available as a specific therapy for HBV/HDV co-infection.
引用
收藏
页码:948 / 954
页数:7
相关论文
共 24 条
  • [1] A case of HBV-induced liver failure in the REEF-2 phase II trial: Implications for finite treatment strategies in HBV 'cure'
    Agarwal, Kosh
    Lok, James
    Carey, Ivana
    Shivkar, Yatin
    Biermer, Michael
    Berg, Thomas
    Lonjon-Domanec, Isabelle
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 (01) : 245 - 248
  • [2] A 3-year course of bulevirtide monotherapy may cure HDV infection in patients with cirrhosis
    Anolli, Maria Paola
    Degasperi, Elisabetta
    Allweiss, Lena
    Sangiovanni, Angelo
    Maggioni, Marco
    Scholtes, Caroline
    Oberhardt, Valerie
    Neumann-Haefelin, Christoph
    Dandri, Maura
    Zoulim, Fabien
    Lampertico, Pietro
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 (04) : 876 - 880
  • [3] Hepatitis D Virus Infection
    Asselah, Tarik
    Rizzetto, Mario
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (01) : 58 - 70
  • [4] Biallas R., 2023, EPID B, V31, P3, DOI DOI 10.25646/11669
  • [5] S3 Guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) for the Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection (AWMF Register No. 021-11)
    Cornberg, Markus
    Sandmann, Lisa
    Protzer, Ulrike
    Niederau, Claus
    Tacice, Frank
    Berg, Thomas
    Glebe, Dieter
    Jilg, Wolfgang
    VVedemeyer, Heiner
    VVirth, Stefan
    Siederdissen, Christoph Hoener zu
    Lynen-Jansen, Petra
    van Leeuwen, Pia
    Petersen, Joerg
    Ciesek, Sandra
    Timm, Joerg
    Knop, Viola
    Schirrnacher, Peter
    Schuettler, Christian
    Buggisch, Peter
    Tannapfel, Andrea
    Jochum, Christoph
    Hinrichsen, Holger
    Kautz, Achim
    Peiffer, Kai-Henrik
    Sarrazin, Christoph
    Schott, Eckart
    Dikopoulos, Nektarios
    Kroy, Daniela
    Sprinzl, Martin
    van Bornmel, Florian
    van Thiel, Ingo
    Vermehren, Johannes
    Wursthorn, Karsten
    Zeuzem, Stefan
    Manns, Michael P.
    Berg, Christoph
    Herzer, Kerstin
    Maasoumy, Benjamin
    Sterneck, Martina
    Aehling, Niklas
    Trowe, Eqbert
    Strassburg, Christian
    Gerlich, Wolfram
    Kallinowski, Birgit
    zur Wiesch, Julian Schulze
    Verheyen, Jens
    Wicker, Sabine
    Wranlce, Anika
    Klinker, Hartwig
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (07): : 691 - 776
  • [6] Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis
    Daher, Darine
    El Dahan, Karim Seif
    Cano, Alva
    Gonzales, Michael
    Ransom, Crystal
    Jaurez, Erik
    Carranza, Osiris
    Quirk, Lisa
    Morgan, Todd
    Gopal, Purva
    Patel, Madhukar S.
    Lieber, Sarah
    Louissaint, Jeremy
    Cotter, Thomas G.
    Vanwagner, Lisa B.
    Yang, Ju Dong
    Parikh, Neehar D.
    Yopp, Adam
    Rich, Nicole E.
    Singal, Amit G.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (02) : 295 - 304.e2
  • [7] Bulevirtide-based treatment strategies for chronic hepatitis delta: A review
    Degasperi, Elisabetta
    Anolli, Maria Paola
    Lampertico, Pietro
    [J]. JOURNAL OF VIRAL HEPATITIS, 2023, 30 : 26 - 32
  • [8] Dietz-Fricke C, 2023, J HEPATOL, V78, pS108
  • [9] Treating hepatitis D with bulevirtide-Real-world experience from 114 patients
    Dietz-Fricke, Christopher
    Tacke, Frank
    Zollner, Caroline
    Demir, Munevver
    Schmidt, Hartmut H.
    Schramm, Christoph
    Willuweit, Katharina
    Lange, Christian M.
    Weber, Sabine
    Denk, Gerald
    Berg, Christoph P.
    Grottenthaler, Julia M.
    Merle, Uta
    Olkus, Alexander
    Zeuzem, Stefan
    Sprinzl, Kathrin
    Berg, Thomas
    van Bommel, Florian
    Wiegand, Johannes
    Herta, Toni
    Seufferlein, Thomas
    Zizer, Eugen
    Dikopoulos, Nektarios
    Thimme, Robert
    Neumann-Haefelin, Christoph
    Galle, Peter R.
    Sprinzl, Martin
    Lohse, Ansgar W.
    zur Wiesch, Julian Schulze
    Kempski, Jan
    Geier, Andreas
    Reiter, Florian P.
    Schlevogt, Bernhard
    Goediker, Juliana
    Hofmann, Wolf Peter
    Buggisch, Peter
    Kahlhofer, Julia
    Port, Kerstin
    Maasoumy, Benjamin
    Cornberg, Markus
    Wedemeyer, Heiner
    Deterding, Katja
    [J]. JHEP REPORTS, 2023, 5 (04)
  • [10] EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
    Lampertico P.
    Agarwal K.
    Berg T.
    Buti M.
    Janssen H.L.A.
    Papatheodoridis G.
    Zoulim F.
    Tacke F.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 370 - 398